Evidence map›Paper›PMID 29471356›Full record

ArticleThe Journal of infectious diseases2018

Characterization of p57, a Stage-Specific Antigen of Pneumocystis murina.

Lisa R Bishop, A Sally Davis, Kaitlynn Bradshaw, Monica Gamez, Ousmane H Cisse, Honghui Wang, Liang Ma, Joseph A Kovacs

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Retracing the evolution ofMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  2. Article
  3. Axenic Long-Term Cultivation ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. The 14th International Workshops on Opportunistic Protists (IWOP 14).The Journal of eukaryotic microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lisa R BishopCritical Care Medicine Department, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland.
A Sally DavisDiagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan.
Kaitlynn BradshawDiagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan.
Monica GamezDiagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan.
Ousmane H CisseCritical Care Medicine Department, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland.
Honghui WangCritical Care Medicine Department, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland.
Liang MaCritical Care Medicine Department, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland.
Joseph A KovacsCritical Care Medicine Department, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland.
National Institutes of Health Clinical Center · USKansas State University · US

Funding

The Characterization of Pneumocystis Surface AntigensZIACL000037 · CLC · CLINICAL CENTER · PI KOVACS, JOSEPH A · 2009 to 2018
$0k
6 · The paper itself

Abstract

Pneumocystis has a large multicopy gene family encoding proteins related to the major surface glycoprotein (Msg), whose functions are largely unknown. We expressed one such protein of Pneumocystis murina, p57, which is encoded by 3 highly conserved genes, and demonstrated by immunoblot that immunocompetent mice that were immunized with crude Pneumocystis antigens or that had cleared Pneumocystis infection developed antibodies to p57. Using hyperimmune anti-p57 serum combined with immunolabeling, we found that p57 was expressed by small trophic forms and intracystic bodies, whereas it was not expressed on larger trophic forms or externally by cysts. Expression of p57 and Msg by trophic forms was largely mutually exclusive. Treatment of infected animals with caspofungin inhibited cyst formation and markedly decreased p57 expression. While p57 expression was seen in immunocompetent mice infected with Pneumocystis, immunization with recombinant p57 did not result in altered cytokine expression by lymphocytes or in diminished infection in such mice. Thus, p57 appears to be a stage-specific antigen of Pneumocystis that is expressed on intracystic bodies and young trophic forms and may represent a mechanism to conserve resources in organisms during periods of limited exposure to host immune responses.

Indexed as

AnimalsAntibodies, FungalAntigens, FungalBlotting, WesternDisease Models, AnimalGene ExpressionMice, Inbred C57BLMice, KnockoutPneumocystisPneumocystis InfectionsAntibodies, FungalAntigens, Fungal

Identifiers

PMID29471356
PMCPMC6279149
OpenAlexW2793867428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.